The GLP is committed to full transparency. Download and review our 2019 Annual Report

Molecular pharming: Could cancer treatments one day grow on trees?

| | July 18, 2018
pills x
Image: YourNewsWire
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Could you imagine a world in which clinical treatments for illnesses such as cancer grew on trees? Professor Julian Ma of St George’s, University of London, UK, is doing just this: growing antibodies – proteins made by the immune system to target pathogens – in transgenic tobacco plants.

This manufacturing technique, called molecular pharming, has been in development for 20 years, but regulatory hurdles have only recently been overcome. Now, molecular pharming facilities worldwide are growing regulatory-standard biopharmaceuticals using robotic automation.

Read full, original article: How Plant Biotechnology Can Give Us Better Food and Medicines

Related article:  Deadly brain disease could be treated in the womb with gene therapy
Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend